A prescription medicine used to treat gout is suspected to have caused 10 deaths in the nation over the past eight years due to side effects that can sometimes be severe, the Food and Drug Administration (FDA) said yesterday.
Colchicine, a strong anti-inflammatory that is widely used to treat gout, has been used in the nation for nearly 40 years and is one of the available options for the frontline treatment of people with gout.
A total of 17 colchicine products have been licensed by the FDA and about 38 million colchicine tablets are sold in the nation each year, the FDA said.
However, from 2011 to August this year, the FDA received 353 reports suggesting adverse reactions to the drug, mostly among patients with renal and liver dysfunction, with 10 deaths believed to be linked to the problem.
Serious side effects of colchicine include blood disease, muscle weakness and neuropathy, said Hung Kuo-teng (洪國登), head of the Medicinal Products Division.
People with renal or hepatic impairment and those who also take other drugs for chronic diseases could experience serious side effects from colchicine, Hung said.
Colchicine is used to relieve the pain and swelling of an acute gout episode and people who experience acute gout attacks usually take the drug for five to seven days.
People with frequent acute flare-ups or chronic gout tend to use it on a long-term basis, said Chen Ming-han (陳明翰), an attending physician at Taipei Veterans General Hospital’s Division of Allergy, Immunology and Rheumatology.
Because of the side effects, doctors tend to prescribe low-dose colchicine for people with renal or hepatic impairment, he said.
Two other medications for gout — benzbromarone and febuxostat — might also increase the risk of side effects, he said.
In Japan, Europe and the US, there have been reports of patients dying of renal failure after using benzbromarone, Chen said.
Considering that most countries issue more than five denominations of banknotes, the central bank has decided to redesign all five denominations, the bank said as it prepares for the first major overhaul of the banknotes in more than 24 years. Central bank Governor Yang Chin-lung (楊金龍) is expected to report to the Legislative Yuan today on the bank’s operations and the redesign’s progress. The bank in a report sent to the legislature ahead of today’s meeting said it had commissioned a survey on the public’s preferences. Survey results showed that NT$100 and NT$1,000 banknotes are the most commonly used, while NT$200 and NT$2,000
The Centers for Disease Control (CDC) yesterday reported the first case of a new COVID-19 subvariant — BA.3.2 — in a 10-year-old Singaporean girl who had a fever upon arrival in Taiwan and tested positive for the disease. The girl left Taiwan on March 20 and the case did not have a direct impact on the local community, it said. The WHO added the BA.3.2 strain to its list of Variants Under Monitoring in December last year, but this was the first imported case of the COVID-19 variant in Taiwan, CDC Deputy Director-General Lin Ming-cheng (林明誠) said. The girl arrived in Taiwan on
South Korea is planning to revise its controversial electronic arrival card, a step Taiwanese officials said prompted them to hold off on planned retaliatory measures, a South Korean media report said yesterday. A Yonhap News Agency report said that the South Korean Ministry of Foreign Affairs is planning to remove the “previous departure place” and “next destination” fields from its e-arrival card system. The plan, reached after interagency consultations, is under review and aims to simplify entry procedures and align the electronic form with the paper version, a South Korean ministry official said. The fields — which appeared only on the electronic form
The Ministry of Foreign Affairs (MOFA) is suspending retaliation measures against South Korea that were set to take effect tomorrow, after Seoul said it is updating its e-arrival system, MOFA said today. The measures were to be a new round of retaliation after Taiwan on March 1 changed South Korea's designation on government-issued alien resident certificates held by South Korean nationals to "South Korea” from the "Republic of Korea," the country’s official name. The move came after months of protests to Seoul over its listing of Taiwan as "China (Taiwan)" in dropdown menus on its new online immigration entry system. MOFA last week
RSS